• CONTINUUS Awarded $69.3M DoD Grant contractpharma
    January 25, 2021
    CONTINUUS Pharmaceuticals Inc. received a $69.3 million U.S. government contract to facilitate domestic production of three vital medicines used to treat critically ill patients, including COVID-19.
PharmaSources Customer Service